Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-04-02 5:24 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Point72 Asset Management L.P. | 2,315,166 5.1% | 2,315,166 (New Position) | View |
2020-02-14 11:43 am Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | ARK Investment Management LLC | 5,077,807 11.96% | 2,617,186 (+106.36%) | View |
2020-02-13 4:50 pm Sale | 13G | SYROS PHARMACEUTICALS INC SYRS | ARCH Venture Fund VII L.P. | 3,341,770 7.9% | -1,295,367 (-27.93%) | View |
2020-02-12 5:14 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Nikko Asset Management Americas Inc. | 4,974,662 11.72% | 668,938 (+15.54%) | View |
2020-02-12 06:09 am Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Sumitomo Mitsui Trust Holdings Inc. | 4,974,662 11.72% | 668,938 (+15.54%) | View |
2020-02-07 11:30 am Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | FMR LLC | 6,406,909 14.999% | 1,358,751 (+26.92%) | View |
2020-02-07 08:45 am Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | BlackRock Inc. BLK | 2,863,412 6.7% | 789,481 (+38.07%) | View |
2019-09-09 06:22 am Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Sumitomo Mitsui Trust Holdings Inc. | 4,305,724 10.15% | 4,305,724 (New Position) | View |
2019-09-06 2:11 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Nikko Asset Management Americas Inc. | 4,305,724 10.15% | 4,305,724 (New Position) | View |
2019-05-10 1:40 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | BlackRock Inc. BLK | 2,073,931 4.9% | 87,801 (+4.42%) | View |